Niki BioSolutions Files 8-K Adding Omitted Financial Statements & Exhibits

What Happened
Niki BioSolutions, Inc. (NIKI) filed a Form 8-K on August 21, 2026 (Accession No. 0001213900-26-092689) to supply financial statements and exhibits that had been excluded from its Original Form 8-K. The filing amends Item 9.01 (Financial Statements and Exhibits) by filing those missing exhibits and expressly incorporates them by reference into the original 8-K. The company stated all other items in the Original Form 8-K remain unchanged.

Key Details

• Item updated: 9.01(a) — financial statements and exhibits that were previously excluded are now filed as exhibits.
• Filing date: August 21, 2026 (8-K amendment/accession 0001213900-26-092689).
• The newly filed exhibits are incorporated by reference into the Original Form 8-K.
• The company confirmed no other changes to the Original Form 8-K (no new earnings, executive changes, or material events reported).

Why It Matters
This is an administrative update that ensures investors and the market have the complete set of financial statements and exhibits tied to the earlier 8-K. It does not introduce new financial results or executive changes — it simply remedies an omission so the company’s disclosure record is complete and transparent. Investors tracking filings should note the exhibits are now available for review.